4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-21-040454
Chief Financial Officer sold 8,000 shares at $25.00 ($200,000)
- Chief Financial Officer acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Trigilio Jeffrey · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-15 | Exercise or conversion : show line 1 in the form | +8,000 | $4.30 | $34,400 | 10,250 | D |
| 2021-10-15 | Sale : show line 2 in the form | −8,000 | $25.00 | $200,000 | 2,250 | D |
| Open-market sales · 8,000 sh · avg $25.00 · $200,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-15 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −8,000 | 229,891 | D |
Loading xslF345X03/doc4.xml…